arrow
B

Brendon L. Neuen

UNSW Sydney
H指数:39
被引数:9,138

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An individual patient meta-analysis assessed the associations between change in albuminuria and acute changes in the glomerular filtration rate in randomized controlled trials of chronic kidney disease progression

一项个体患者Meta分析评估了慢性肾病进展的随机对照试验中,白蛋白尿变化与肾小球滤过率急性变化之间的关联

2026-09-300
PRE
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: insights from the CREDENCE trial

卡格列净在CKD患者中不同联合用药负担下的疗效和安全性具有一致性:来自CREDENCE试验的见解

2026-09-040
OAAI
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

住院是导致2型糖尿病患者停用钠-葡萄糖协同转运蛋白2抑制剂的一个强风险因素

2026-08-280
OAAI
Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure

慢性肾脏病或心力衰竭患者中同时启动SGLT2抑制剂和盐皮质激素受体拮抗剂的疗效与安全性

2026-05-150
PRE
Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes

根据慢性肾脏病和2型糖尿病基线心力衰竭风险,非奈利酮对心力衰竭结局的影响

2026-03-250
OAAI
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2

SGLT2抑制剂在估计肾小球滤过率恶化至<20ml/min/1.73m²的2型糖尿病合并CKD患者中的应用

2026-02-270
OAAI
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality A Retrospective Observational Study Based on National General Practice Dataset

eGFR的变异性与不良肾脏结局和全因死亡风险:一项基于全国基层医疗数据库的回顾性观察研究

2026-02-010
PRE
The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy A Systematic Review and Meta-Analysis

低级别蛋白尿与IgA肾病不良肾脏结局之间的关联:一项系统评价和荟萃分析

2025-12-010
PRE
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes

Finerenone在心力衰竭和伴有2型糖尿病的慢性肾脏病中心血管和肾脏获益的时间点

JACC
IF0
2025-11-180
OAAI
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

白蛋白尿作为终末期肾病替代终点的荟萃分析

2025-11-060
PRE
Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

澳大利亚初级保健中异常eGFR和UACR随访检测模式的慢性肾病筛查:一项全国综合诊所数据集分析

2025-10-010
OAAI